Shungin D, Deng WQ, Varga TV, et al. Ranking and characterization of established BMI and lipid associated loci as candidates for gene-environment interactions. PLoS Genet. 2017;13(6):e1006812. doi:10.1371/journal.pgen.1006812.
Zekavat SM, Ruotsalainen S, Handsaker RE, et al. Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat Commun. 2018;9(1):2606. doi:10.1038/s41467-018-04668-w.
Natarajan P, Peloso GM, Zekavat SM, et al. Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat Commun. 2018;9(1):3391. doi:10.1038/s41467-018-05747-8.
Xu Y-X, Redon V, Yu H, et al. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. Atherosclerosis. 2018;268:196-206. doi:10.1016/j.atherosclerosis.2017.08.031.
Hindy G, Engström G, Larsson SC, et al. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study. Stroke. 2018;49(4):820-827. doi:10.1161/STROKEAHA.117.019653.
Musunuru K, Kathiresan S. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis. Circ Res. 2016;118(4):579-85. doi:10.1161/CIRCRESAHA.115.306398.
Natarajan P, O'Donnell CJ. Reducing Cardiovascular Risk Using Genomic Information in the Era of Precision Medicine. Circulation. 2016;133(12):1155-9. doi:10.1161/CIRCULATIONAHA.116.021765.
Musunuru K, Lettre G, Young T, et al. Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet. 2010;3(3):267-75. doi:10.1161/CIRCGENETICS.109.882696.
Natarajan P, Kathiresan S. PCSK9 Inhibitors. Cell. 2016;165(5):1037. doi:10.1016/j.cell.2016.05.016.
Musunuru K, Romaine SPR, Lettre G, et al. Multi-ethnic analysis of lipid-associated loci: the NHLBI CARe project. PLoS One. 2012;7(5):e36473. doi:10.1371/journal.pone.0036473.